Develop therapeutic monoclonal antibodies.
Ablynx’s proprietary Nanobody platform allows for the rapid generation and large-scale production of novel biological therapeutics that have potential in a wide range of human diseases.
Abraxis develops, manufactures, and markets rapid environmental, food, and life sciences test systems, including immunochemistry products and methods, to meet the testing needs of research and ...
Antibodies, Kits, etc
Adagene balances human engineering and natural properties in their antibody design as they strive to cure disease.
Aduro’s three proprietary technology platforms (Live, Attenuated Double-Deleted Listeria (LADD), STING Pathway Activators, and B-select monoclonal antibodies) have the potential to transform the ...
Equipment and antibodies for immunoassays
Agenus uses the power of the immune system to develop innovative product candidates against cancer. The company has assembled a broad portfolio of antibodies including checkpoint inhibitors and ...
AgomAb is developing molecular therapies for the regeneration of damaged tissues using monoclonal antibody molecules (“agomAbs”) to stimulate molecular and cellular repair mechanisms that have the ...
Akoya has developed the CODEX Technology to provide a comprehensive solution for spatially-resolved, highly multiplexed biomarker analysis.
Alder BioPharmaceuticals is developing monoclonal antibody therapeutics for the treatment of migraine, Cushing’s disease, Congenital Adrenal Hyperplasia and autoimmune and inflammatory diseases.